Close

Carcinoma

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Carcinoma is a kind of cancer that derived from epithelial cells. It begins from the cells of the skin or the tissue lining the entire surfaces of the body, such as the liver or the kidneys. Carcinoma occurs when the DNA of a cell is damaged or changed and the cell begins to grow out of control. They become abnormal and subsequentlly invade other tissues. Carcinomas happen more often in adults whereas rare among children before their adolescence.

Carcinomas mainly include renal cell carcinoma, melanoma, cervical carcinoma, adenocarcinomas, lung malignancy, colorectal cancer, prostate cancer and breast cancer. Depending on the various tissues carcinomas originating from, the sign and symptom might vary. However, the most common symptom is a lump under the skin, other symtoms may include skin discolorations, pains, etc.

Creative Biolabs provides CAR modified T cells or natural killer (NK) cells targeting a variety of carcinoma-specific antigens. If you require any further information, please do not hesitate to contact us.

Carcinoma can be divided into different groups:

Renal cell carcinoma
Melanoma
Cervical carcinoma
Colorectal cancer
Prostate cancer
Breast cancer
Pancreatic cancer
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.